137 related articles for article (PubMed ID: 12183660)
1. Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes.
Swiergiel AH; Dunn AJ
J Pharmacol Exp Ther; 2002 Sep; 302(3):1031-6. PubMed ID: 12183660
[TBL] [Abstract][Full Text] [Related]
2. The role of cyclooxygenases in endotoxin- and interleukin-1-induced hypophagia.
Dunn AJ; Swiergiel AH
Brain Behav Immun; 2000 Sep; 14(3):141-52. PubMed ID: 10970676
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase 1 is not essential for hypophagic responses to interleukin-1 and endotoxin in mice.
Swiergiel AH; Dunn AJ
Pharmacol Biochem Behav; 2001; 69(3-4):659-63. PubMed ID: 11509229
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase 2 pathway mediates IL-1beta regulation of IL-1alpha, -1beta, and IL-6 mRNA levels in Leydig cell progenitors.
Walch L; Morris PL
Endocrinology; 2002 Sep; 143(9):3276-83. PubMed ID: 12193539
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis.
Zhang X; Morham SG; Langenbach R; Young DA; Xing L; Boyce BF; Puzas EJ; Rosier RN; O'Keefe RJ; Schwarz EM
J Bone Miner Res; 2001 Apr; 16(4):660-70. PubMed ID: 11315993
[TBL] [Abstract][Full Text] [Related]
7. COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production.
Johnson PM; Vogt SK; Burney MW; Muglia LJ
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E650-6. PubMed ID: 11832369
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1beta-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling.
Gray T; Nettesheim P; Loftin C; Koo JS; Bonner J; Peddada S; Langenbach R
Mol Pharmacol; 2004 Aug; 66(2):337-46. PubMed ID: 15266025
[TBL] [Abstract][Full Text] [Related]
9. Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice.
Wormser U; Langenbach R; Peddada S; Sintov A; Brodsky B; Nyska A
Toxicol Appl Pharmacol; 2004 Oct; 200(1):40-7. PubMed ID: 15451306
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis.
Kuwano T; Nakao S; Yamamoto H; Tsuneyoshi M; Yamamoto T; Kuwano M; Ono M
FASEB J; 2004 Feb; 18(2):300-10. PubMed ID: 14769824
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells.
Fehrenbacher JC; Burkey TH; Nicol GD; Vasko MR
Pain; 2005 Jan; 113(1-2):113-22. PubMed ID: 15621371
[TBL] [Abstract][Full Text] [Related]
12. Specific roles of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain.
Zhang YH; Lu J; Elmquist JK; Saper CB
J Comp Neurol; 2003 Aug; 463(1):3-12. PubMed ID: 12811798
[TBL] [Abstract][Full Text] [Related]
13. Central cyclooxygenase inhibitors reduced IL-1beta-induced hyperalgesia in temporomandibular joint of freely moving rats.
Ahn DK; Chae JM; Choi HS; Kyung HM; Kwon OW; Park HS; Youn DH; Bae YC
Pain; 2005 Sep; 117(1-2):204-13. PubMed ID: 16098663
[TBL] [Abstract][Full Text] [Related]
14. Differential involvement of cyclooxygenase isoforms in neutrophil migration in vivo and in vitro.
Menezes GB; Rezende RM; Pereira-Silva PE; Klein A; Cara DC; Francischi JN
Eur J Pharmacol; 2008 Nov; 598(1-3):118-22. PubMed ID: 18823975
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
Kusunoki N; Yamazaki R; Kawai S
Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting.
Davis TW; Zweifel BS; O'Neal JM; Heuvelman DM; Abegg AL; Hendrich TO; Masferrer JL
J Pharmacol Exp Ther; 2004 Mar; 308(3):929-34. PubMed ID: 14711936
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells.
Harizi H; Norbert G
Cell Immunol; 2004 Apr; 228(2):99-109. PubMed ID: 15219461
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
Oka T; Shearer T; Azuma M
Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
[TBL] [Abstract][Full Text] [Related]
20. Genetic deficiency or pharmacological inhibition of cyclooxygenase-1 or -2 induces mouse keratinocyte differentiation in vitro and in vivo.
Akunda JK; Lao HC; Lee CA; Sessoms AR; Slade RM; Langenbach R
FASEB J; 2004 Jan; 18(1):185-7. PubMed ID: 14630706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
